Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
申请人:Favor David
公开号:US20060234997A1
公开(公告)日:2006-10-19
Compounds of formula 1
are disclosed, wherein G, D, A, Q, Y, Z, and R
1
through R
10
are defined in the specification. Also provided are descriptions of processes for preparing compounds of formula 1, intermediates used in making the same, and pharmaceutical compositions containing such compounds and their use in the treatment of central nervous system disorders and other disorders.
The present invention relates to novel compounds of formula (I)′ or a salt thereof:
wherein G is selected from a group consisting of: phenyl, a 5- or 6-membered monocyclic heteroaryl group, or a 8- to 11-membered heteroaryl bicyclic group; A is a group P1 or a group P2 wherein
P1 is
and the other groups are define in herein.
作者:V. V. Smirnov、V. M. Zelikman、I. P. Beletskaya、E. N. Golubeva、D. S. Tsvetkov、M. M. Levitskii、M. A. Kazankova
DOI:10.1023/a:1020889209717
日期:——
Quantitative catalytic bromination of alkanes, cycloalkanes, and arylalkanes with carbon tetrabromide as brominating agent was accomplished for the, first time.
<b>Photobromination of Alkyl Halides, an Unusual Orienting Effect in the Bromination of Alkyl Bromides</b>
作者:Warren. Thaler
DOI:10.1021/ja00900a019
日期:1963.9
VAPOR PHASE BROMINATION OF ALKYL HALIDES
作者:M. S. KHARASCH、WERNER S. ZIMMT、WALTER NUDENBERG